The Fairlight Global Small and Mid Cap Fund has retained a “4 IP” rating from Research IP, with a score of 3.77/5. Research IP was notified recently about a change to Ian Carmichael’s role, this has led to a small change in the rating score.
The Fairlight Global Small and Mid Cap Fund (“the Fund”) invests in a portfolio of global small and mid capitalisation companies drawn from international equity markets outside Australia.
The Fund is an international equities fund, targeting undervalued small and mid capitalisation securities on the world’s stock markets. Global small and mid cap companies are the largest investment universe with the least amount of broker research coverage. Historically, global small and mid cap companies have generally outperformed global large cap companies over the long term.
What is the Fund’s competitive advantage?
Qualitative Research Report and Data Tear Sheet
Research IP says
“The Manager’s investment approach is underpinned by robust fundamental analysis alongside constructive quantitative analysis. The small and mid cap segment of the global equity universe is inherently risky given the size of the companies, though this is mitigated somewhat through the Manager’s awareness of risk (at the company and Fund level) and focus on quality.“
“The team’s alignment of interest with investors is close to as good as it gets within the managed fund industry. 100% of the investment team are invested in the Fund. This alignment is backed by each of the team member’s equity holdings in Fairlight.”“Research IP highlights the custom-built analytics system utilised by the Manager. The system provides the investment team with easy access to stock summaries, notes, financials, graphs, ESG considerations, bench research, and portfolio decisions over time.”
Research IP, 1 April 2023
If you have any questions in relation to this report or the Research IP services, please contact us here.
Disclaimer, Disclosures and Warnings
Research IP strongly recommends this document and report be read in conjunction with the relevant Product Disclosure Statement. Research IP gives no warranty of accuracy or completeness of information in this document. Any information, opinions, views or recommendations are general information only and do not take into consideration any person’s particular financial situation or goals and therefore does not constitute financial advice. This document should not be relied upon as a substitute for financial advice from your financial adviser.
Comments are closed